These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36330472)

  • 1. Health-related quality of life measured by EQ-5D-3L for the spouses of breast cancer patients.
    Sun LF; Huang S; Li YF; Yang ZQ; Yang XJ; Zou JY; Wang XW; Nie JY
    Front Oncol; 2022; 12():983704. PubMed ID: 36330472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and reliability of EQ-5D-3L for breast cancer patients in Korea.
    Kim SH; Jo MW; Lee JW; Lee HJ; Kim JK
    Health Qual Life Outcomes; 2015 Dec; 13():203. PubMed ID: 26694964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construct validity and reliability of EQ-5D-3L for stroke survivors in a lower middle income setting.
    Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Senanayake S; Senanayake C; De Silva LSD; Kularatna S
    Ceylon Med J; 2019 Jun; 64(2):52-58. PubMed ID: 31455067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
    Khanna R; Jariwala K; Bentley JP
    Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran.
    Zare F; Ameri H; Madadizadeh F; Aghaei MR
    Diabetes Metab Syndr; 2021; 15(1):319-324. PubMed ID: 33486224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and validity of the EQ-5D-3L for Kashin-Beck disease in China.
    Fang H; Farooq U; Wang D; Yu F; Younus MI; Guo X
    Springerplus; 2016; 5(1):1924. PubMed ID: 27917330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meaningful values of the EQ-5D-3L in patients undergoing primary knee arthroplasty.
    Yapp LZ; Scott CEH; Howie CR; MacDonald DJ; Simpson AHRW; Clement ND
    Bone Joint Res; 2022 Sep; 11(9):619-628. PubMed ID: 36047008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe.
    Mafirakureva N; Dzingirai B; Postma MJ; van Hulst M; Khoza S
    AIDS Care; 2016 Jul; 28(7):904-12. PubMed ID: 27098289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the European Quality of Life-5 Dimensions, 3-Level Version (EQ-5D-3L) in Patients With Osteoporotic Vertebral Fracture and Comparing Their Health-Related Quality of Life With That of the General Population in Korea.
    Jeong JH; Jo MW; Chin DK; Son WS; Ock M; Lee JK
    Korean J Neurotrauma; 2022 Apr; 18(1):64-74. PubMed ID: 35557648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping.
    Gray LA; Wailoo AJ; Hernandez Alava M
    Value Health; 2018 Dec; 21(12):1399-1405. PubMed ID: 30502783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
    Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF
    Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and reliability of the Chichewa translation of the EQ-5D quality of life questionnaire in adults with orthopaedic injuries in Malawi.
    Chokotho L; Mkandawire N; Conway D; Wu HH; Shearer DD; Hallan G; Gjertsen JE; Young S; Lau BC
    Malawi Med J; 2017 Jun; 29(2):84-88. PubMed ID: 28955412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and internal consistency of EQ-5D-3L quality of life tool among pre-dialysis patients with chronic kidney disease in Sri Lanka, a lower middle-income country.
    Senanayake S; Mahesh PKB; Gunawardena N; Graves N; Kularatna S
    PLoS One; 2019; 14(6):e0211604. PubMed ID: 31242189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea.
    Kim SH; Kim HJ; Lee SI; Jo MW
    Qual Life Res; 2012 Aug; 21(6):1065-73. PubMed ID: 21947656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.
    Willems LM; Knake S; Rosenow F; Reese JP; Conradi N; Strzelczyk A
    Epilepsy Behav; 2022 Feb; 127():108554. PubMed ID: 35063789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To what extent does the EQ-5D-3L correlate with the FACT-H&N of patients with oral cancer during the perioperative period?
    Aoki T; Ota Y; Sasaki M; Aoyama KI; Akiba T; Shirasugi Y; Naito M; Shiroiwa T
    Int J Clin Oncol; 2019 Apr; 24(4):350-358. PubMed ID: 30392116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
    Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
    Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric properties of the EQ-5D-3L in South Australia: a multi-method non-preference-based validation study.
    Zakershahrak M; Ribeiro Santiago PH; Sethi S; Haag D; Jamieson L; Brennan D
    Curr Med Res Opin; 2022 May; 38(5):673-685. PubMed ID: 35060425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where's WALY? : A proof of concept study of the 'wellbeing adjusted life year' using secondary analysis of cross-sectional survey data.
    Johnson R; Jenkinson D; Stinton C; Taylor-Phillips S; Madan J; Stewart-Brown S; Clarke A
    Health Qual Life Outcomes; 2016 Sep; 14(1):126. PubMed ID: 27608769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.